HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Related articles in The JI Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ghosh, S. Articles by Huber, B. T. Search for Related Content PubMed PubMed Citation Articles by Ghosh, S. Articles by Huber, B. T.

Autoantibodies from Synovial Lesions in Chronic, Antibiotic Treatment-Resistant Lyme Arthritis Bind Cytokeratin-10¹

Srimoyee Ghosh^*, Robert Seward, Catherine E. Costello, B. David Stollar and Brigitte T. Huber^2,*

^* Department of Pathology, Tufts University School of Medicine, Boston, MA 02111; Department of Biochemistry, Tufts University School of Medicine, Boston, MA 02111; and Mass Spectrometry Resource, Boston University School of Medicine, Boston, MA 02118

Although the causative agent of Lyme disease is definitively known to be the tick-borne spirochete, Borrelia burgdorferi, the etiology of chronic joint inflammation that ensues in a subset of patients remains less well understood. Persistence of arthritis after apparent eradication of the spirochete suggests an autoimmune reaction downstream of the original bacterial infection. We have generated recombinant Ab probes from synovial lesions within affected arthritic joints in an attempt to recapitulate disease-relevant Ag-binding specificities at the site of injury. Using this panel of intra-articular probes, as well as Ab fragments derived from patient peripheral blood, we have identified cytokeratin 10, present in synovial microvascular endothelium, as a target ligand and a putative autoantigen in chronic, antibiotic treatment-resistant Lyme arthritis. Furthermore, there is cross-reactivity between cytokeratin 10 and a prominent B. burgdorferi Ag, outer surface protein A. Release of the self protein in the context of inflammation-induced tissue injury and the resulting in situ response to it could set in motion a feed-forward loop, which amplifies the inflammatory process, thereby rendering it chronic and self-perpetuating, even in the absence of the inciting pathogen.

Related articles in The JI:

IN THIS ISSUE

The JI 2006 177: 2033-2034. [Full Text]  

This article has been cited by other articles:

				A. Vojdani, F. Hebroni, Y. Raphael, J. Erde, and B. Raxlen Novel Diagnosis of Lyme Disease: Potential for CAM Intervention Evid. Based Complement. Altern. Med., September 1, 2009; 6(3): 283 - 295. [Abstract] [Full Text] [PDF]

				T. J. LaRocca, L. I. Katona, D. G. Thanassi, and J. L. Benach Bactericidal Action of a Complement-Independent Antibody against Relapsing Fever Borrelia Resides in Its Variable Region J. Immunol., May 1, 2008; 180(9): 6222 - 6228. [Abstract] [Full Text] [PDF]

				Y.-F. Hsieh, H.-W. Liu, T.-C. Hsu, J. C.-C. Wei, C.-M. Shih, P. J. Krause, and G. J. Tsay Serum Reactivity against Borrelia burgdorferi OspA in Patients with Rheumatoid Arthritis Clin. Vaccine Immunol., November 1, 2007; 14(11): 1437 - 1441. [Abstract] [Full Text] [PDF]